Successful treatment of a refractory intestinal Behcet’s disease with an oncology history by Vedolizumab: a case report and literature review

OBJECTIVE: Behçet’s Disease (BD) is an intractable systemic vasculitis. When accompanied by intestinal symptoms, the prognosis is usually poor. 5-Aminosalicylic acid (5-ASA), corticosteroids, immunosuppressive drugs, and anti-tumor necrosis factor-α (anti-TNF-α) biologics are standard therapies to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ruixia, Li, Xiaofei, Zhou, He, Shi, Yanting, Wang, Fang, Wu, Tong, Liang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242066/
https://www.ncbi.nlm.nih.gov/pubmed/37287984
http://dx.doi.org/10.3389/fimmu.2023.1205046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242066/
https://www.ncbi.nlm.nih.gov/pubmed/37287984
http://dx.doi.org/10.3389/fimmu.2023.1205046

Ejemplares similares